Early Stage
September Is National Leukemia and Lymphoma Awareness Month
(09/02/2008)
As the month of September brings leukemia and lymphoma into focus, it’s a great time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment options, and resources that offer updated leukemia and lymphoma information throughout the year.
Differences in IMRT Radiation Doses May Complicate Study Results in Lymphomas
(04/07/2008)
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in lymphomas difficult to interpret. These findings were reported in the Journal of the National Cancer Institute.
Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer
(02/29/2008)
Hodgkin’s lymphoma survivors may be at risk for secondary cancer. These findings were recently reported in the British Journal of Cancer.
Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma
(02/05/2008)
A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics and possible treatment options for both types of disease. These results were published in the Journal of Clinical Oncology.
Annual Mammography Alone Not Sufficient for Young Hodgkin’s Survivors
(01/09/2008)
According to the results of a study published in the Annals of Oncology, annual screening mammography may miss some cases of early invasive breast cancer among young Hodgkin’s lymphoma survivors who were treated with supradiaphragmatic (above the diaphragm) radiation therapy.
More...
Advanced Stage
September Is National Leukemia and Lymphoma Awareness Month
(09/02/2008)
As the month of September brings leukemia and lymphoma into focus, it’s a great time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment options, and resources that offer updated leukemia and lymphoma information throughout the year.
Hodgkin’s Lymphoma Survivors May Be at Risk for Secondary Cancer
(02/29/2008)
Hodgkin’s lymphoma survivors may be at risk for secondary cancer. These findings were recently reported in the British Journal of Cancer.
Better Prognosis for Patients with Lymphocyte-predominant Hodgkin’s Lymphoma
(02/05/2008)
A recent study compared lymphocyte-predominant Hodgkin’s lymphoma (LPHL) and classical Hodgkin’s lymphoma (cHL) in order to define differences in patient characteristics and possible treatment options for both types of disease. These results were published in the Journal of Clinical Oncology.
Patients with Hodgkin’s at Risk for Heart Attack Later in Life
(02/14/2007)
According to results from the Journal of the National Cancer Institute, patients treated for Hodgkin’s lymphoma are at an increased risk for death from a heart attack for 25 years.
Increase in Hodgkin’s Lymphoma in HAART Era
(01/03/2007)
Among people living with AIDS, the frequency of Hodgkin’s lymphoma has increased since the introduction of highly active antiretroviral therapy (HAART). These results were published in the journal Blood.
More...
Progressive Relapsed
September Is National Leukemia and Lymphoma Awareness Month
(09/02/2008)
As the month of September brings leukemia and lymphoma into focus, it’s a great time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment options, and resources that offer updated leukemia and lymphoma information throughout the year.
Autologous Stem Cell Transplantation Effective for Relapsed Hodgkin’s Lymphoma
(07/31/2008)
Autologous stem cell transplantation is effective for patients with Hodgkin’s lymphoma that has progressed following prior therapies. These results were recently published in the Annals of Oncology.
Patients with Hodgkin’s at Risk for Heart Attack Later in Life
(02/14/2007)
According to results from the Journal of the National Cancer Institute, patients treated for Hodgkin’s lymphoma are at an increased risk for death from a heart attack for 25 years.
Increase in Hodgkin’s Lymphoma in HAART Era
(01/03/2007)
Among people living with AIDS, the frequency of Hodgkin’s lymphoma has increased since the introduction of highly active antiretroviral therapy (HAART). These results were published in the journal Blood.
Addition of Interferon Following an Autologous Stem Cell Transplant Provides Impressive Outcomes for Children with Recurrent Hodgkin's
(08/29/2006)
According to an article recently published in Bone Marrow Transplantation, the addition of the biologic agent interferon following an autologous stem cell transplant provides impressive outcomes for pediatric patients with Hodgkin's lymphoma that has stopped responding to prior therapies.
More...